Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant by Satish Dayal, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Margaret Moline, Larisa Reyderman, Ishani Landry

Get full text

Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial by Yoshikazu Takaesu, Masahiro Suzuki, Margaret Moline, Kate Pinner, Kanako Inabe, Yurie Nishi, Kenichi Kuriyama

Get full text

Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant by Ishani Landry, Jagadeesh Aluri, Nancy Hall, Gleb Filippov, Satish Dayal, Margaret Moline, Larisa Reyderman

Get full text

Transitioning insomnia patients from zolpidem to lemborexant: A multicenter, open-label study evaluating a next-dose transition approach to insomnia pharmacotherapy by Maha Ahmad, James Kelly, C. Brendan Montano, Dinesh Kumar, Carlos Perdomo, Manoj Malhotra, Jess Amchin, Margaret Moline

Get full text

Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review by Taro Kishi, Maika Nishida, Michinori Koebis, Takehiro Taninaga, Kenzo Muramoto, Naoki Kubota, Margaret Moline, Kenji Sakuma, Makoto Okuya, Ikuo Nomura, Nakao Iwata

Get full text

Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder by Amitabh Dash, Kate Pinner, Yuichi Inoue, Kenichi Hayashida, Sung Chul Lim, Chang-Ho Yun, Tsuo-Hung Lan, Chieh-Liang Huang, Jane Yardley, Naoki Kubota, Margaret Moline

Get full text